Cargando…

Recombinant Human Insulin in Global Diabetes Management – Focus on Clinical Efficacy

Biosynthetic human insulin and insulin analogues are the mainstay of insulin therapy for both type 1 and type 2 diabetes although access to human insulin at affordable prices remains a global issue. The world is experiencing an exponential rise in the prevalence of diabetes presenting an urgent need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbanya, Jean Claude, Sandow, Juergen, Landgraf, Wolfgang, Owens, David R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Touch Medical Media 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813441/ https://www.ncbi.nlm.nih.gov/pubmed/29632602 http://dx.doi.org/10.17925/EE.2017.13.01.21

Ejemplares similares

Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy
por: Landgraf, Wolfgang, et al.
Publicado: (2016)

Centenary of the discovery of insulin: People with diabetes in Africa still have poor access to insulin
por: Mbanya, Jean Claude, et al.
Publicado: (2021)

A global perspective on the issue of access to insulin
por: Beran, David, et al.
Publicado: (2021)

Global accessibility of therapeutics for diabetes mellitus
por: Fralick, Michael, et al.
Publicado: (2022)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS)
por: Chan, Juliana C. N., et al.
Publicado: (2021)

Healthcare providers’ and policymakers’ experiences and perspectives on barriers and facilitators to chronic disease self-management for people living with hypertension and diabetes in Cameroon
por: Mogueo, Amélie, et al.
Publicado: (2022)

African Cuisine-Centered Insulin Therapy: Expert Opinion on the Management of Hyperglycaemia in Adult Patients with Type 2 Diabetes Mellitus
por: Mbanya, Jean Claude, et al.
Publicado: (2020)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management
por: Gramza, Ann, et al.
Publicado: (2009)

The Relationship between Adiposity and Insulin Sensitivity in African Women Living with the Polycystic Ovarian Syndrome: A Clamp Study
por: Doh, Emmanuella, et al.
Publicado: (2016)

Day-to-Day Variation of Insulin Requirements of Patients With Type 2 Diabetes and End-Stage Renal Disease Undergoing Maintenance Hemodialysis
por: Sobngwi, Eugene, et al.
Publicado: (2010)

Stepwise intensification of insulin therapy in Type 2 diabetes management—exploring the concept of the basal-plus approach in clinical practice
por: Owens, D R
Publicado: (2013)

Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical Trials
por: Bastyr, Edward J., et al.
Publicado: (2015)

Metabolic syndrome for sub-Saharan Africans diabetes with peripheral arterial disease: a case-control study
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Diabetes-related foot disorders among adult Ghanaians
por: Sarfo-Kantanka, Osei, et al.
Publicado: (2018)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Le Floch, Jean-Pierre
Publicado: (2010)

Can nutrition interventions tackle the global insulin affordability via improving diabetes management and reducing insulin demand?
por: Lu, Victoria, et al.
Publicado: (2022)

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
por: Owens, David R., et al.
Publicado: (2019)

Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
por: Mba, Camille Maadjhou, et al.
Publicado: (2019)

Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS)
por: Mbanya, Jean Claude, et al.
Publicado: (2021)

Risk factors of impaired fasting glucose and type 2 diabetes in Yaoundé, Cameroon: a cross sectional study
por: Kufe, Clement Nyuyki, et al.
Publicado: (2015)

Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius
por: Mbanya, Armand, et al.
Publicado: (2022)

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)
por: Aschner, Pablo, et al.
Publicado: (2020)

Global Patterns of Recombination across Human Viruses
por: Patiño-Galindo, Juan Ángel, et al.
Publicado: (2021)

High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study
por: Aschner, Pablo, et al.
Publicado: (2021)

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
por: Thuillier, Philippe, et al.
Publicado: (2015)

Efficacy and safety of two protocols of intravenous insulin therapy in the management of diabetic ketoacidosis
por: Jouini, Sarra, et al.
Publicado: (2022)

Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes
por: Mittendorfer, Bettina, et al.
Publicado: (2011)

An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
por: Gilor, Chen, et al.
Publicado: (2021)

Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs
por: Hulsebosch, Sean E., et al.
Publicado: (2022)

Impact of a pioneer diabetes camp experience on glycemic control among children and adolescents living with type 1 diabetes in sub-Saharan Africa
por: Dehayem, Mesmin Y., et al.
Publicado: (2016)

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
por: Raslova, Katarina
Publicado: (2010)

Insulin glulisine in the management of diabetes
por: Yamada, Satoru
Publicado: (2009)

Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies
por: Feldman, Francis, et al.
Publicado: (2021)

Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value
por: Clissold, Rhian, et al.
Publicado: (2007)

Setting-up nurse-led pilot clinics for the management of non-communicable diseases at primary health care level in resource-limited settings of Africa
por: Kengne, Andre Pascal, et al.
Publicado: (2009)

Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes
por: Jean-Baptiste, Eddy, et al.
Publicado: (2021)

Application of the modified Framingham cardiovascular risk score to newly diagnosed type 2 black African diabetic patients
por: Kengne, Andre Pascal, et al.
Publicado: (2007)

Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015- a retrospective cohort study
por: Sarfo-Kantanka, Osei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bc9og4ngvsm6ob6hsutut98vai